Correlation Between Shenzhen Mindray and Jiangsu Phoenix

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Shenzhen Mindray and Jiangsu Phoenix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shenzhen Mindray and Jiangsu Phoenix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shenzhen Mindray Bio Medical and Jiangsu Phoenix Publishing, you can compare the effects of market volatilities on Shenzhen Mindray and Jiangsu Phoenix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shenzhen Mindray with a short position of Jiangsu Phoenix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shenzhen Mindray and Jiangsu Phoenix.

Diversification Opportunities for Shenzhen Mindray and Jiangsu Phoenix

-0.11
  Correlation Coefficient

Good diversification

The 3 months correlation between Shenzhen and Jiangsu is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Shenzhen Mindray Bio Medical and Jiangsu Phoenix Publishing in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jiangsu Phoenix Publ and Shenzhen Mindray is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shenzhen Mindray Bio Medical are associated (or correlated) with Jiangsu Phoenix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jiangsu Phoenix Publ has no effect on the direction of Shenzhen Mindray i.e., Shenzhen Mindray and Jiangsu Phoenix go up and down completely randomly.

Pair Corralation between Shenzhen Mindray and Jiangsu Phoenix

Assuming the 90 days trading horizon Shenzhen Mindray Bio Medical is expected to under-perform the Jiangsu Phoenix. But the stock apears to be less risky and, when comparing its historical volatility, Shenzhen Mindray Bio Medical is 1.08 times less risky than Jiangsu Phoenix. The stock trades about -0.17 of its potential returns per unit of risk. The Jiangsu Phoenix Publishing is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  1,063  in Jiangsu Phoenix Publishing on September 12, 2024 and sell it today you would earn a total of  49.00  from holding Jiangsu Phoenix Publishing or generate 4.61% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Shenzhen Mindray Bio Medical  vs.  Jiangsu Phoenix Publishing

 Performance 
       Timeline  
Shenzhen Mindray Bio 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Shenzhen Mindray Bio Medical are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shenzhen Mindray sustained solid returns over the last few months and may actually be approaching a breakup point.
Jiangsu Phoenix Publ 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Jiangsu Phoenix Publishing has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Jiangsu Phoenix is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Shenzhen Mindray and Jiangsu Phoenix Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Shenzhen Mindray and Jiangsu Phoenix

The main advantage of trading using opposite Shenzhen Mindray and Jiangsu Phoenix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shenzhen Mindray position performs unexpectedly, Jiangsu Phoenix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jiangsu Phoenix will offset losses from the drop in Jiangsu Phoenix's long position.
The idea behind Shenzhen Mindray Bio Medical and Jiangsu Phoenix Publishing pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Fundamental Analysis
View fundamental data based on most recent published financial statements
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments